Stockscreener 앱 받기
8.739
0.17%
-0.011
전일 마감가:
$8.75
열려 있는:
$8.71
하루 거래량:
188.25K
Relative Volume:
0.17
시가총액:
$769.17M
수익:
$47.56M
순이익/손실:
$-156.83M
주가수익비율:
-4.7754
EPS:
-1.83
순현금흐름:
$-127.98M
1주 성능:
+5.62%
1개월 성능:
+9.05%
6개월 성능:
-32.39%
1년 성능:
-51.39%
1일 변동 폭
$8.665
$8.90
1주일 범위
$8.185
$8.90
52주 변동 폭
$6.38
$19.09
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
명칭
Avadel Pharmaceuticals Plc
전화
636-449-1830
주소
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
AVDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
8.7399 | 769.17M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
155.51 | 65.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.24 | 46.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.96B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.21B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
300.34 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-06-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-05 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-05 | 재확인 | Needham | Buy |
| 2024-03-05 | 재확인 | Oppenheimer | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2022-11-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-28 | 재개 | Craig Hallum | Buy |
| 2022-05-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 개시 | Needham | Buy |
| 2020-07-31 | 개시 | Oppenheimer | Outperform |
| 2020-07-21 | 개시 | SVB Leerink | Outperform |
| 2020-06-30 | 개시 | H.C. Wainwright | Buy |
| 2020-04-03 | 개시 | Jefferies | Buy |
| 2020-03-12 | 개시 | Stifel | Buy |
| 2020-02-26 | 개시 | Piper Sandler | Overweight |
| 2020-01-30 | 개시 | Craig Hallum | Buy |
| 2019-06-14 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
모두보기
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
UBS Adjusts Avadel Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating - marketscreener.com
LPL Financial LLC Purchases 10,072 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
JPMorgan Chase & Co. Has $1.17 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (AVDL)’s Market Momentum: Closing Strong at 8.60, Up 3.49 - DWinneX
Avadel Pharmaceuticals plc (AVDL)’s stock performance: a year in review - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
AVDL Stock Sees Surge of Approximately 5.06% in Last Five Days - knoxdaily.com
Avadel Pharmaceuticals plc (AVDL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Geode Capital Management LLC Acquires 10,886 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Russell Investments Group Ltd. Acquires 11,350 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Alliancebernstein L.P. Boosts Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Insider Buying: Palczuk Linda, Avadel Pharmaceuticals plc [AVDL] Director invested 5,000 shares - knoxdaily.com
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience - TradingView
Equities Analysts Offer Predictions for AVDL Q1 Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q2 Earnings - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability - Yahoo Finance
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Set To Breakeven - simplywall.st
Vanguard Group Inc. Buys 90,147 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Needham & Company LLC Reiterates Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Stock Position Decreased by Corebridge Financial Inc. - Defense World
Avadel reports steady demand and patent lawsuits By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals updates at healthcare conference By Investing.com - Investing.com South Africa
Avadel Highlights Improved Demand for LUMRYZ at Conference - TipRanks
Avadel Pharmaceuticals updates at healthcare conference - Investing.com
Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025 - MarketScreener
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference - The Manila Times
Avadel reports steady demand and patent lawsuits - Investing.com
KLP Kapitalforvaltning AS Purchases New Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Sold by Commonwealth Equity Services LLC - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of “Buy” by Analysts - Defense World
AVDL Stock Sees Decline of Approximately -8.69% in Last Five Days - knoxdaily.com
Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times
When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News
Is Avadel Pharmaceuticals plc (AVDL) worth investing in despite its overvalued state? - uspostnews.com
Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st
Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Avadel Pharmaceuticals Plc (AVDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Avadel Pharmaceuticals Plc 주식 (AVDL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
1.42%
자본화:
|
볼륨(24시간):